Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,007 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Disruption of insulin receptor substrate 2 (IRS2) causes non-obese type 2 diabetes with β-cell dysfunction in the golden (Syrian) hamster.
Hirose M, Inoue K, Matoba S, Tatebe T, Tokita S, Dodo Y, Tomishima T, Hasegawa A, Honda A, Ozaki M, Shinogi A, Yanagisawa R, Fauzi M, Murakami T, Inagaki N, Tamura M, Ogura A. Hirose M, et al. Among authors: inagaki n. Sci Rep. 2024 Aug 12;14(1):17450. doi: 10.1038/s41598-024-67513-9. Sci Rep. 2024. PMID: 39134590 Free PMC article.
Big insulin-like growth factor 2-producing multiple solitary fibrous tumors treated with debulking surgery: A case report.
Keidai Y, Murakami T, Yamamura N, Tsunoda S, Ikeda A, Hida K, Nagao M, Yamada Y, Fukui A, Ogura M, Fukuda I, Nakamoto Y, Obama K, Inagaki N. Keidai Y, et al. Among authors: inagaki n. Front Endocrinol (Lausanne). 2023 Jan 20;14:1071899. doi: 10.3389/fendo.2023.1071899. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 36742395 Free PMC article.
Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials.
Hasebe M, Yoshiji S, Keidai Y, Minamino H, Murakami T, Tanaka D, Fujita Y, Harada N, Hamasaki A, Inagaki N. Hasebe M, et al. Among authors: inagaki n. Cardiovasc Diabetol. 2023 Mar 19;22(1):62. doi: 10.1186/s12933-023-01773-z. Cardiovasc Diabetol. 2023. PMID: 36935489 Free PMC article.
Correction: Efficacy of antihyperglycemic therapies on cardiovascular and heart failure outcomes: an updated meta-analysis and meta-regression analysis of 35 randomized cardiovascular outcome trials.
Hasebe M, Yoshiji S, Keidai Y, Minamino H, Murakami T, Tanaka D, Fujita Y, Harada N, Hamasaki A, Inagaki N. Hasebe M, et al. Among authors: inagaki n. Cardiovasc Diabetol. 2023 Apr 24;22(1):95. doi: 10.1186/s12933-023-01825-4. Cardiovasc Diabetol. 2023. PMID: 37095496 Free PMC article. No abstract available.
A hyperaldosteronism subtypes predictive model using ensemble learning.
Karashima S, Kawakami M, Nambo H, Kometani M, Kurihara I, Ichijo T, Katabami T, Tsuiki M, Wada N, Oki K, Ogawa Y, Okamoto R, Tamura K, Inagaki N, Yoshimoto T, Kobayashi H, Kakutani M, Fujita M, Izawa S, Suwa T, Kamemura K, Yamada M, Tanabe A, Naruse M, Yoneda T; JPAS/JRAS Study Group. Karashima S, et al. Among authors: inagaki n. Sci Rep. 2023 Feb 21;13(1):3043. doi: 10.1038/s41598-023-29653-2. Sci Rep. 2023. PMID: 36810868 Free PMC article.
18F-labeled PEGylated exendin-4 imaging noninvasively differentiates insulinoma from an accessory spleen: the first case report of [18F]FB(ePEG12)12-exendin-4 positron emission tomography/computed tomography for insulinoma.
Sakaki K, Murakami T, Fujimoto H, Shimizu Y, Miyake KK, Otani D, Kiyobayashi S, Okada T, Fujimoto M, Hakata T, Yamauchi I, Shimada K, Shimizu H, Nagai K, Nakamoto Y, Inagaki N. Sakaki K, et al. Among authors: inagaki n. Front Endocrinol (Lausanne). 2023 Aug 31;14:1245573. doi: 10.3389/fendo.2023.1245573. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37720533 Free PMC article.
1,007 results